Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Xopenex HFA (Levalbuterol Tartrate) Inhalation Aerosol
Company: Sepracor Inc.
Application No.:  021730
Approval Date: 03/11/2005


Date created: December 132006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.